Results

Mustang Bio Inc.

12/01/2020 | Press release | Distributed by Public on 12/01/2020 07:12

Mustang Bio to Host Key Opinion Leader Call on MB-106 for the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma